Pulmonary cancer tumor markers

Due to the fact that lung cancer is most often an asymptomatic disease, an important percentage of patients are diagnosed in an advanced stage of the disease when a curative treatment is no longer possible. Studies have shown that identification and determination of specific serum tumor markers might play a key role in order to detect the disease, monitor the response to surgery or chemotherapy and provide an early detection of the recurrences. This is a literature review regarding the role of monitoring pulmonary cancer tumor markers such as NSE, CYFRA 21-1, SCC, CEA, CA 125, ferritin, proGRP, IDH1 or CA 19-9.

Disclaimer

“The journal is open-access. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles and allow readers to use them for any other lawful purpose”.